According to Frederick C. Nucifora, M.D., director of the Adult Schizophrenia Clinic at the Johns Hopkins School of Medicine, as many as 30 percent of patients with schizophrenia would benefit ...
The FDA has eliminated the need for pharmacists to verify a patient's white blood cell count before dispensing the antipsychotic medication clozapine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback